By Aurax Desk | 05, 2026 | 2 min read
Contrary to long‑held assumptions, a new study shows that many adults aged 80 and older with early‑stage lung cancer can safely undergo surgery and achieve survival outcomes similar to younger patients, offering hope for expanded treatment options in older populations.
Lung cancer surgery for patients over age 80 is increasingly seen as safe and effective, according to new research.
A recent study from researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center has found that surgery for early‑stage lung cancer can be safe and effective for many patients aged 80 and older, challenging longstanding medical assumptions that advanced age should automatically exclude them from operative treatment.
The research, published in The Lancet Regional Health – Americas, looked at surgical outcomes and long‑term survival for patients diagnosed with early‑stage non‑small cell lung cancer (NSCLC). It compared results between older adults — including those aged 81 to 85 — and younger cohorts. Remarkably, the five‑year survival rate for the older group reached 84.2 percent, closely approaching the 87.3 percent seen in younger patients.
Study shows survival outcomes for early‑stage lung cancer surgery are comparable between older and younger patients
Although postoperative complications were somewhat more frequent among the older group — a factor medical teams expect given age differences — many patients in both groups reported significant improvements in quality of life a year after surgery.
Traditional clinical practice has often steered older patients away from curative surgery because of perceived risks related to frailty and recovery. However, this study underscores that chronological age alone should not be the deciding factorin treatment decisions. Instead, patient selection based on overall health status and fitness for surgery may be a more equitable and effective approach.
Experts say these findings could influence future lung cancer screening and treatment guidelines, ensuring that older adults who are otherwise good candidates receive access to potentially life‑saving surgery. As populations continue to age globally, such evidence may help reduce treatment disparities and improve outcomes for older cancer patients.
Sources: MedicalXpress, Mount Sinai Press Release, Reuters/Yahoo Health